Clinical trial
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of…
NCT03789656 · Crinetics Pharmaceuticals Inc., Industry · Completed
Key facts
| NCT number | NCT03789656 |
|---|---|
| Title | An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) |
| Official title | An Open Label Exploratory Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients With Acromegaly Treated With Somatostatin Analogue Based Treatment Regimens (ACROBAT Edge) |
| Lead sponsor | Crinetics Pharmaceuticals Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Paltusotine |
| Enrollment | 47 |
| Start date | Mar 12, 2019 |
| Primary completion | Aug 3, 2020 |
| Completion | Aug 31, 2020 |
| First posted | Dec 28, 2018 |
| Last update posted | Feb 17, 2025 |
| Countries | Brazil, Germany, Greece, Hungary, Italy, New Zealand, Poland, Romania, Serbia, Slovakia, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: